CHINO, CA--(Marketwired - Jun 22, 2015) -  KollagenX® Corp. (OTCQB: KGNX) KollagenX establishes European distribution through exclusive distribution agreement with AMN Euro Health.

KollagenX is pleased to announce that it is expanding its global footprint by signing an exclusive distribution agreement with Serbian-based AMN Euro health. AMN Euro Health is one of Serbia's largest and longest serving distributors with over 10 years of providing quality health and skin care products to the Serbian market. Their distribution channels range from pharmacies to a strong online presence.

The agreement was consummated with an initial order of approximately $50,000USD or about 3000 varied units of its various products. "We are extremely excited to be taking that important step of expanding global market presence of our product and brand. The initial PO also strengthens our corporate resolve to keep growing, getting more orders and potentially increasing shareholder value," said KollagenX CEO, George Huerta.

About KollagenX®

KollagenX® is a California based cosmetic company that's main focus is nano gold technology also known as NGT®. KollagenX® was formed by Rondell Fletcher and George Huerta in early 2008. KollagenX® develops and introduces new safe, more affordable eco-friendly NGT® products that will help improve the quality of lives. The company's unique anti-aging skin care products restore a natural youthful glow and a smoother, supplier appearance. KollagenX® helps bring the nourishment your skin needs to be healthier and function more effectively.

For more information on KollagenX® Corp:

Forward-Looking Statements
Forward-Looking Statement Any statements made in this press release which are not historical facts contain certain forward-looking statements; as such term is defined in the Private Security Litigation Reform Act of 1995, concerning potential developments affecting the business, prospects, financial condition and other aspects of the company to which this release pertains. The actual results of the specific items described in this release, and the company's operations generally, may differ materially from what is projected in such forward-looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company's dependence on third parties, general market and economic conditions, technical factors, the availability of outside capital, receipt of revenues and other factors, many of which are beyond the control of the company. The company disclaims any obligation to update information contained in any forward-looking statement. This press release shall not be deemed a general solicitation.

Contact Information:

KollagenX Corp.
(909) 465-1784